Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers comprehensive insights into Fluzone Quadrivalent, a vaccine used for seasonal influenza, across the six major markets. It provides a detailed overview of Fluzone Quadrivalent for seasonal influenza in the 6MM (United States, EU4: Germany, France, Italy, and Spain, and the United Kingdom) during the study period